SAP SE closed at $206.36 on September 11, 2026, up +0.20% from $205.95, and for the first time in two weeks the tape delivered genuinely constructive news: the September 11 intraday low of $204.61 held above the rising at $204.00 on a closing basis for a second consecutive session, and the macro regime repaired meaningfully — collapsed -11.21% to 15.84 (back inside the Risk-On band), the S&P 500 rose +0.86%, the Nasdaq +0.96%, and the Dow +0.98%, a sharp reversal from the September 10 de-risking session. The momentum picture, however, remains unconflicted in its deterioration: the histogram widened for a sixth straight session to -2.904 (from -2.795), the line fell to 4.30 against the signal at 7.21, stalled at 49.92 — still the sub-50 zone that ended the two-month recovery — and while ticked up to -8.03M from -9.75M, the bounce came on just 1.72M shares (0.73x the 2.35M 20-day average), which is stabilization rather than institutional accumulation. Fundamentals are unchanged and constructive: Q2 cloud revenue grew 24% cc, the €22.93B backlog grows 24.6% organically, FY2026 cloud guidance of €25.8-26.2B is maintained, near-term estimates are firming (Q3 at $2.08969, up from $2.05602 60 days ago) with zero downward revisions in the last 30 days, and short interest has fallen to 0.44% of float with a 1.96 ratio. The unresolved bear thesis remains UBS's August 26 downgrade — 17 of 200 targeted AI agents delivered, cloud gross margin before SBC fell for the first time since 2021 on AI token costs, no Rule of Forty this decade — against visibly faster peer monetization (Salesforce Agentforce ARR +240% to $1.5B+, Workday agentic ARR +200% to ~$600M). Consensus stands at 4 Strong Buy/9 Buy/3 Hold/0 Sell with the $247.25 mean target implying +19.9% upside from $206.36. Next earnings is October 21, 39 days away — the event that must answer the UBS thesis. The decisive monitorable is unchanged: hold above the with histogram contraction and an uptick would validate the $200-207 accumulation zone and re-arm the $213.77-223.28 supply zone; a daily close below $200 confirms structural breakdown toward $188-195 and mandates re-underwriting.
投资判断
实时价格
$206.36
推荐分数
56%
56%
置信度
64%
64%
各期限展望
1个月
持有
短线
6个月
持有
中期
1年
买入
长期
核心催化
The September 11 session delivered two offsetting market-setters: the at $204.00 was defended for a second consecutive close (intraday low $204.61) AND collapsed -11.21% to 15.84 with all indices green — the first alignment of a structural support defense with a friendly macro tape since the correction began. But the confirmation machinery is still armed in reverse: the histogram hit -2.904, its widest negative reading of the entire recovery, and the uptick came on the lightest volume in three weeks. The resolution gates on sequence: histogram contraction plus an above-average-volume recovery validates the $200-207 accumulation zone and re-arms a $213.77 breakout test toward the $218.68-223.28 supply zone ahead of October 21; a daily close below $200 instead confirms structural breakdown and projects $195-188, forcing a full re-underwrite before management's October 21 rebuttal of the UBS thesis.
稳定性分类Balanced Growth组合角色Core Growth回撤风险Medium风险画像ModerateEnterprise SoftwareEMA200 Defense HeldMACD Histogram Still WideningVIX Normalize to 15.84Agentic AI Execution GapOctober 21 SetupCloud Backlog Visibility
决策工作台
价格地图
60日设置
价格轨道
$206.36
止损
当前
$193
$212
$232
$252
止损位
$197.50
买入
$200.00 - $207.00
止盈
$230.00 - $247.25
风险/回报
4.9x
有吸引力
到止损下行
-4.3%
到止盈上行
+19.8%
仓位提示
at 15.84 (-11.21%, back inside the Risk-On band) is a tailwind, but the histogram at -2.904 (its widest negative reading of the recovery) and an uptick on 0.73x volume forbid aggressive positioning: hold 50-60% of normal weight in tactical exposure with the stop below the structure, and size any core remainder to withstand a $188-195 overshoot. Accumulation inside the $200-207 zone is valid only with confirmation evidence (2-3 sessions of histogram contraction plus an above-average-volume recovery) — not on the knife itself. Re-engagement trigger: a volume-backed reclaim of the at $213.77. If price closes below $200 on any meaningful volume, cut tactical exposure entirely and re-underwrite the fundamental thesis before redeploying.
投资逻辑快照
什么情况涨
The prior analysis demanded exactly one thing from the tape — a defended — and got it: two consecutive closes above the $204.00 line, including a clean $204.61 intraday hold on September 11 after the $203.74 pierce, with contracting from 6.25 to 5.97 and the first uptick of the distribution streak (-8.03M from -9.75M). Simultaneously the macro headwind reversed in a single session: -11.21% to 15.84 with all major indices green, restoring the Risk-On regime under which a net-cash, 0.775-beta franchise gets a stabilization bid. The fundamentals never flinched during the ~8% slide: 24% cc cloud growth, €22.93B backlog up 24.6% organically, maintained €25.8-26.2B cloud guidance, 73.66% gross margins, $1.69B net cash, a 3.82% FCF yield that improved with the drawdown, near-term estimates firming (Q3 $2.08969, Q4 $2.37486) with zero downward revisions in 30 days, and short interest down to 0.44% of float. Consensus is 4 Strong Buy/9 Buy/3 Hold/0 Sell with the mean target +19.9% away, no insiders sold, and peer prints (CRM Agentforce +240%, WDAY agentic ARR +200%) prove the enterprise-AI budget pool is expanding — SAP's system-of-record position and €22.93B backlog mean that pool eventually flows through its P&L. Buying a 26.7%-below-high, net-cash, dividend-paying franchise at its 200-day line with 39 days until management's rebuttal, inside the prior analysis' own pre-defined accumulation zone, is precisely the risk the target distribution says is worth taking.
什么情况跌
The single most important momentum indicator got worse on the good-news day: the histogram widened to -2.904, the deepest negative reading of the entire recovery, on the very session the stock 'stabilized' — and the uptick that bulls will cite came on 0.73x average volume, the lightest session in three weeks. That is not accumulation; it is a seller strike at support, and a seller strike at support fails violently the moment a seller of size returns. When the prior analysis' own framework triggered this cleanly ( break, through -$7M, five supply-zone rejections) and only the final close-below was averted by 24 cents on one session, calling the bottom is guesswork, not process. UBS's thesis is unanswered and accumulating evidence: 17 of 200 agents delivered versus last year's 10-of-40 record, cloud gross margin before SBC fell for the first time since 2021 on token costs, FY2026 EBIT was trimmed €100M, and the Zacks peer note now publishes the comparison everyone can see — CRM at 16.30x forward with $1.5B+ Agentforce ARR and +26% since its print, versus SAP at a premium multiple with 17 agents and a broken chart. FY2027 estimates remain ~1.2% below their 90-day level, the 10-year rose to 4.97% on the rally day itself, and if the tape is pricing a CCB deceleration below the ~23% guide before Q3 confirms it, the next leg is $195-188 and holders enter October 21 — the event that must answer UBS — with a structurally failed chart.
A daily close below $200 — through the at $204.00 with follow-through past one (5.97) toward the $197.50 stop level — confirms the two-session defense was a failed base and mandates exiting tactical exposure entirely and re-underwriting core exposure; the confirmations are already armed ( histogram at -2.904 and widening, recovery on sub-average volume). Fundamentally, Q3 constant-currency cloud-backlog growth below ~22% or FY2026 cloud-revenue guidance below €25.8B on October 21 would invalidate the re-rating thesis outright.
Momentum has not confirmed the base: the histogram widened to -2.904 on the September 11 stabilization session — the widest negative reading of the recovery — and the uptick came on 0.73x average volume; a single heavy-volume down day through $204 would validate the distribution thesis and open $195-188 within days, ahead of the October 21 print.
The agentic-AI execution gap is quantified, published, and relative: 17 out-of-the-box agents delivered versus a 200 ambition (UBS: 'challenging'), against Salesforce's $1.5B+ Agentforce ARR (+240%) and Workday's ~$600M agentic ARR (+200%), while the Zacks peer note documents SAP's forward-multiple premium (23.48x at publication) over CRM (16.30x) and ORCL (17.99x) — every peer print that widens the gap erodes the multiple premium before management's October 21 rebuttal.
Rates and IT-budget risk cap the recovery: the 10-year rose to 4.97% even on the September 11 risk-on session, mechanically compressing 21.34x-forward software multiples, and UBS flags that management's own IT-spending caution since the Gulf conflict began will resurface as CCB growth slows in the second half — a sustained move through 5.0% would likely carry price through the regardless of backlog data.
Margin economics are deteriorating at the margin: cloud gross margin before SBC fell for the first time since 2021 on AI token costs, FY2026 EBIT guidance was trimmed €100M on acquisition dilution, and FY2027 estimates sit ~1.2% below their 90-day level ($9.66899 vs $9.78967) — if token-cost compression extends beyond the M&A-dilution explanation, both the 27.62% operating margin and the Rule-of-Forty glide path UBS already abandoned come into question.
接下来关注
下一次财报：2026年10月21日
The September 11 session delivered two offsetting market-setters: the at $204.00 was defended for a second consecutive close (intraday low $204.61) AND collapsed -11.21% to 15.84 with all indices green — the first alignment of a structural support defense with a friendly macro tape since the correction began. But the confirmation machinery is still armed in reverse: the histogram hit -2.904, its widest negative reading of the entire recovery, and the uptick came on the lightest volume in three weeks. The resolution gates on sequence: histogram contraction plus an above-average-volume recovery validates the $200-207 accumulation zone and re-arms a $213.77 breakout test toward the $218.68-223.28 supply zone ahead of October 21; a daily close below $200 instead confirms structural breakdown and projects $195-188, forcing a full re-underwrite before management's October 21 rebuttal of the UBS thesis.
信号仪表盘
决策输入
6 个信号
基本面
19.8%
距分析师均值目标空间
At $206.36, SAP trades at 26.59x trailing and 21.34x forward earnings with a of 1.55 against roughly 12-13% expected growth — reasonable for a franchise with 24% cc cloud growth, though not cheap: the September 8 Zacks peer note confirms SAP's 23.48x forward multiple (at the time) prices a premium to Oracle at 17.99x and a large premium to Salesforce at 16.30x, which means the market is still charging SAP for AI optionality the UBS downgrade argues it is not yet delivering. of 6.24x is supported by 9.4% revenue growth, 24% cc cloud growth, and a 20.41% net margin; the 284.6x is a lease/intangible data artifact and should be disregarded. Cash-flow support holds at a 3.82% FCF yield with $1.69B net cash (0.71% of the $238.18B market cap). The stock sits -26.66% below its $281.37 52-week high at the 45.0% mark of the 52-week range. Against $206.36: the $247.25 mean target is +19.9%, the median $247.50 is +19.9%, the $319 high is +54.6%, and the $177 BMO low is -14.2%. The valuation asymmetry is attractive on a 6-12 month view provided backlog deceleration stays at the guided ~23%; it offers no protection if agentic-AI execution keeps eroding the premium versus CRM and ORCL into October 21.
技术面
Bearish
趋势质量
The defense is now a two-session fact, and that changes the characterization from free-fall to contested base. The September 10 low of $203.74 pierced the by 24 cents before closing at $205.95; on September 11 the intraday low of $204.61 held cleanly above the rising at $204.00 and the close of $206.36 marked the first green close since September 3. The larger structure remains corrective: price is below the at $213.77, the sequence since August 31 is lower highs ($223.28, then $220.33 on September 4) and lower lows ($211.49, $209.14, $205.95, $206.36 marginal), the at $197.24 remains below the in a technically unresolved death-cross configuration (both rising), and five rejections at $218.68-223.28 define the supply overhead. Price is +42.4% above the $144.97 52-week low and -26.66% below the $281.37 high, at the 45.0% mark of the range. Characterization: basing attempt directly on the 200-day line after an active correction — the is the structural floor of the entire $144.97-to-$223.28 recovery, and a daily close below $200 would confirm breakdown toward $195-188.
财报
39天
Decelerating
Q2 2026 non-IFRS of $1.81 missed consensus of $2.00 by 9.8% on acquisition dilution and AI token costs, but revenue beat at $11.48B (+12.1% YoY) with cloud up 24% cc and backlog up ~26% cc — the market prioritized the demand signals and rallied, a reaction that has since been fully unwound by the September correction.
新闻
Mixed-Bearish
新闻基调
The September 11 session delivered two offsetting market-setters: the at $204.00 was defended for a second consecutive close (intraday low $204.61) AND collapsed -11.21% to 15.84 with all indices green — the first alignment of a structural support defense with a friendly macro tape since the correction began. But the confirmation machinery is still armed in reverse: the histogram hit -2.904, its widest negative reading of the entire recovery, and the uptick came on the lightest volume in three weeks. The resolution gates on sequence: histogram contraction plus an above-average-volume recovery validates the $200-207 accumulation zone and re-arms a $213.77 breakout test toward the $218.68-223.28 supply zone ahead of October 21; a daily close below $200 instead confirms structural breakdown and projects $195-188, forcing a full re-underwrite before management's October 21 rebuttal of the UBS thesis.
宏观
Risk-On
4.97% 10Y / 15.8 VIX
at 15.84 (-11.21%) has snapped back inside the Risk-On band with all major indices green on September 11 — a materially friendlier tape for a 21.34x-forward software name sitting on its 200-day line, though the 10-year at 4.97% remains the ceiling on growth-multiple expansion and limits how much regime support SAP actually receives.
稳定性
Balanced Growth
Core Growth
SAP remains a balanced-growth compounder: 73.66% gross margins, 18.32% , $1.69B net cash, a 1.42% dividend, $9.09B of free cash flow (3.82% FCF yield), and a €22.93B cloud backlog growing 24.6% organically give the thesis multi-year visibility and a fundamental floor that pure-growth software names lack. The September 10-11 sessions delivered the first constructive technical development in two weeks — the at $204.00 was defended on a closing basis twice, including a September 11 intraday low of $204.61, and collapsed -11.21% to 15.84 with all major indices green — but momentum has not confirmed: the histogram widened again to -2.904 and sits at 49.92, so a 10-15% drawdown toward $188-195 remains fully possible into the October 21 print. The stock belongs as a Core Growth holding rather than a Core Anchor: the franchise is durable and the 0.775 beta, 3.82% FCF yield, and buyback support provide real downside mechanics, but the 21.34x forward multiple is hostage to the 4.97% 10-year yield and to an agentic-AI execution story (17 of 200 targeted agents delivered per UBS) that will not be resolved until Q3 evidence arrives.
分析师目标区间
均值目标
$247.25
高低目标
$177 / $319
分析师中值目标
$247.50
共识区间
$177 - $319
— 位分析师
Mean
$177$247$319
市场共识
Coverage remains firmly positive: 4 Strong Buy, 9 Buy, 3 Hold, 0 Sell, with the mean target of $247.25 implying +19.9% from $206.36 and the median at $247.50. The $177 low and $319 high frame a $142 disagreement band that itself signals genuine uncertainty about AI-agent monetization. UBS's Neutral is the documented outlier thesis: 17 of 200 agents delivered, cloud gross margin before SBC down for the first time since 2021, CCB fading to ~23%, no Rule of Forty this decade. Zero sell ratings plus a +20% mean target against a price that spent the week pinned to the is the cleanest illustration of the current standoff: the sell side sees value, the chart demanded proof — and the first stabilization evidence (two -defended closes, back to 15.84) has finally arrived, though momentum has not yet confirmed.
筹码脉冲
内部人信号
Neutral
净偏向
No recent activity
内部人持股
0.0%
机构持股
7.8%
解读
Zero insider filings provide no statistical signal, but nobody in the executive population rushed for the exits during the breakdown and the test — a neutral-to-slightly-positive counterweight into the October 21 print.
重要活动
The Form-4 feed contains zero insider transactions across the entire $223.28 (August 31) to $204.61 (September 11 intraday low) round trip, including the breakdown and the two-session defense. No discretionary selling into the weakness is visible in the captured filing population; the sample is empty so no directional conclusion is possible, but the absence of selling across a ~8% peak-to-trough slide is a mildly supportive tell.
市场背景
行业
Software - Application
Mixed-Bullish
情绪
21
跟踪股票
14
分组
industry
Software - Application 行业 当前情绪为 Mixed-Bullish，板块平均评分约 55 分，资金与评分正在同步走强，且leadership is concentrated in CRM, UBER, NOW。
Agentic AI monetization is now quantifiably real across enterprise software — Salesforce's Agentforce ARR topped $1.5B (+240% YoY), Workday's agentic ARR approached $600M (+200% YoY, +20% sequentially) with >5,500 customers using at least one organic agent — proving the category is budgeted and scaling. SAP's problem is relative execution and relative price: UBS counts 17 out-of-the-box agents delivered (15 in ramp) against a 200-by-year-end ambition it calls 'challenging,' while the Zacks peer note shows SAP trading at a forward premium (23.48x at publication, 21.34x now) to Salesforce at 16.30x and Oracle at 17.99x despite CRM's 26% post-earnings rally. SAP remains the system-of-record governance layer with a €22.93B backlog, but the market is allocating the AI premium to demonstrable ARR proof, and the token-cost hit to cloud gross margin shows AI repricing as a cost line for lagging executors. The theme is strengthening for the group and stalling for SAP specifically until the October 21 print.
CRM's 34% one-month rally on Agentforce ARR and WDAY's 49.7% three-month run on agentic ARR quantified the monetization gap in the same two weeks UBS downgraded SAP for delivering 17 of 200 agents — the execution differential is now the price-setting variable into October 21.
Capital is rotating toward demonstrable agentic-AI monetizers: CRM +26% since August 26 on $1.5B+ Agentforce ARR, WDAY +49.7% in three months on ~$600M agentic ARR, while SAP corrected ~8% peak-to-trough on UBS's 17-agent critique and sits on its .
Cloud gross margin before SBC fell for the first time since 2021 on AI token costs and FY2026 EBIT guidance was trimmed €100M on acquisition dilution — for lagging executors the market is repricing AI as a margin cost, not just a revenue line.
Value Rotation in Rate-Sensitive Software
评分: 35
Mixed-Bearish
The risk-on snapback ( -11.21% to 15.84, all indices green on September 11) temporarily revived the value-in-software rotation that SAP's drawdown had been choking on: the stock's value credentials improved mechanically with the slide to 21.34x forward , a 3.82% FCF yield, $1.69B net cash, and a 1.42% dividend at 0.775 beta, and the $247.25 mean target now implies +19.9%. But the 10-year rose to 4.97% even on the rally day, and SAP's 6.24x still carries a premium to CRM's 16.30x forward multiple — meaning the 'value' bid in SAP is relative, not absolute, and it evaporates if yields push the 10-year toward 5%. The rotation thesis remains valid on a 6-12 month horizon and got its first macro tailwind in a week; it needs either yield stabilization or an base with momentum confirmation to re-engage.
collapsing to 15.84 with indices green on the same session the was defended for a second time is the first coordinated macro-plus-technical tailwind since the correction began — but the 4.97% 10-year on that same rally day shows the bond market has not yet ratified the rotation.
SAP's value metrics improved mechanically with the slide — forward from ~22.24x to 21.34x, FCF yield to 3.82% — and the defense on 0.73x volume suggests the forced-selling phase is exhausted; with short interest at just 0.44% of float and zero sell ratings, a yield-stabilization trigger would produce a fast, positioning-light rebound toward the broken .
The 10-year at 4.97% — rising even on the September 11 risk-on session — keeps 21.3x-forward software multiples under mechanical compression; SAP cannot de-rate-proof itself with buybacks alone until the rate backdrop stops deteriorating.
关键指标
23 项指标
市值
$238.18B
市盈率 (TTM)
26.6
远期市盈率
21.3
营收增速
9.4%
净资产收益率
18.3%
Beta 系数
0.77
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
6.2
市净率
65.0
企业价值 / EBITDA
284.6
质量与资产负债表
利润率、杠杆与流动性。
毛利率
73.7%
营业利润率
27.6%
资产负债率
22.0
流动比率
1.15x
速动比率
0.98x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
0.4%
空头回补天数
1.96x
52周最高
$281.37
52周最低
$144.97
距52周高点
-26.7%
距52周低点
42.3%
公司分类
板块与行业背景。
板块
Technology
行业
Software - Application
其他信号
自由现金流
$9090624512.00
详细分析
估值
At $206.36, SAP trades at 26.59x trailing and 21.34x forward earnings with a of 1.55 against roughly 12-13% expected growth — reasonable for a franchise with 24% cc cloud growth, though not cheap: the September 8 Zacks peer note confirms SAP's 23.48x forward multiple (at the time) prices a premium to Oracle at 17.99x and a large premium to Salesforce at 16.30x, which means the market is still charging SAP for AI optionality the UBS downgrade argues it is not yet delivering. of 6.24x is supported by 9.4% revenue growth, 24% cc cloud growth, and a 20.41% net margin; the 284.6x is a lease/intangible data artifact and should be disregarded. Cash-flow support holds at a 3.82% FCF yield with $1.69B net cash (0.71% of the $238.18B market cap). The stock sits -26.66% below its $281.37 52-week high at the 45.0% mark of the 52-week range. Against $206.36: the $247.25 mean target is +19.9%, the median $247.50 is +19.9%, the $319 high is +54.6%, and the $177 BMO low is -14.2%. The valuation asymmetry is attractive on a 6-12 month view provided backlog deceleration stays at the guided ~23%; it offers no protection if agentic-AI execution keeps eroding the premium versus CRM and ORCL into October 21.
资产负债表
SAP holds $11.62B cash against $9.94B debt ($1.69B net cash, 0.71% of market cap). Debt-to-equity is 21.97%, cash-to-debt is 1.17x, operating cash flow covers 95% of total debt, and current/quick ratios are 1.15/0.98. The balance sheet comfortably funds the €10B buyback, the 1.42% dividend at a 37.53% payout, and continued AI investment; with beta of 0.775 and the 10-year at 4.97%, this net-cash structure is a genuine defensive attribute even while the multiple compresses.
增长
Headline revenue growth is 9.4% YoY with earnings growth of 30.6% YoY, but the strategic signal remains cloud: Q2 cloud revenue rose 24% cc and the €22.93B current cloud backlog grows 24.6% organically, with management guiding a 'slight' slowdown to ~23% for the full year. Near-term consensus continues to firm: Q3 at $2.08969 (from $2.05602 60 days ago, $2.0814 30 days ago) and Q4 at $2.37486 (from $2.29818 60 days ago), with the revision feed showing zero downward revisions in the last 7 and 30 days across all buckets and 1-2 upward revisions each. Out-year dollars are still eroding on acquisition dilution and AI token costs: FY2026 at $8.22404 (vs $8.32017 90 days ago) and FY2027 at $9.66899 (vs $9.78967). Net: cloud/backlog momentum remains the growth engine and near-term revisions are positive, but the reported- glide path decelerates and UBS's projection of CCB fading to ~23% with no Rule of Forty this decade is the live debate Q3 must settle.
生意质量
Gross margin of 73.66%, operating margin of 27.62%, margin of 30.79%, of 18.32%, and of 9.54% describe a capital-light, subscription-heavy franchise with mission-critical switching costs — a moat even the UBS downgrade team concedes is 'deep around its core business.' The 0.98 quick ratio is adequate given recurring revenue and $9.46B operating cash flow. The first cloud gross-margin decline before SBC since 2021 on AI token costs is an early warning, but one data point does not break a 73.66%-gross-margin structure. Business quality comfortably supports a low-20s forward multiple; whether it supports re-rating back toward the upper-20s depends on agent-delivery pace and token economics, both unresolved until October 21.
资本配置
Management runs a €10B buyback, pays a 1.42% dividend with a 37.53% payout, and deployed into AI via acquisitions (Dremio, Prior Labs) that trimmed FY2026 EBIT guidance by €100M. Net cash of $1.69B plus $9.46B operating cash flow and $9.09B FCF provides ample flexibility, and at 26.7% below the 52-week high the buyback is accretive. The unresolved trade-off: acquisition dilution cut near-term EBIT and keeps FY2027 estimates ~1.2% below their 90-day level — capital deployed for backlog and AI capability must show return in 2027 estimates or the out-year erosion continues.
预期修正
Constructive and stable: the revision feed shows zero downward revisions in the last 7 and 30 days across the 0q/+1q/0y/+1y buckets, with 1-2 upward revisions each, Q3 firmed to $2.08969 and Q4 to $2.37486 from their 60-day levels. FY2026 ($8.22404 vs $8.32017) and FY2027 ($9.66899 vs $9.78967) remain ~1-1.5% below their 90-day marks — the erosion has stopped but not reversed. Sell-side posture: 4 Strong Buy/9 Buy/3 Hold/0 Sell, up from 3/10/3 two months ago; the UBS downgrade to Neutral (August 26, target raised to €201) is the lone bearish outlier, with Barclays ($242) and TD Cowen ($210) trimming targets on maintained ratings in July.